Journal article
Roux-en-Y gastric bypass-induced bacterial perturbation contributes to altered host-bacterial co-metabolic phenotype
Microbiome, Vol.9(1), Art. 139
2021
Abstract
Background
Bariatric surgery, used to achieve effective weight loss in individuals with severe obesity, modifies the gut microbiota and systemic metabolism in both humans and animal models. The aim of the current study was to understand better the metabolic functions of the altered gut microbiome by conducting deep phenotyping of bariatric surgery patients and bacterial culturing to investigate causality of the metabolic observations.
Methods
Three bariatric cohorts (n = 84, n = 14 and n = 9) with patients who had undergone Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG) or laparoscopic gastric banding (LGB), respectively, were enrolled. Metabolic and 16S rRNA bacterial profiles were compared between pre- and post-surgery. Faeces from RYGB patients and bacterial isolates were cultured to experimentally associate the observed metabolic changes in biofluids with the altered gut microbiome.
Results
Compared to SG and LGB, RYGB induced the greatest weight loss and most profound metabolic and bacterial changes. RYGB patients showed increased aromatic amino acids-based host-bacterial co-metabolism, resulting in increased urinary excretion of 4-hydroxyphenylacetate, phenylacetylglutamine, 4-cresyl sulphate and indoxyl sulphate, and increased faecal excretion of tyramine and phenylacetate. Bacterial degradation of choline was increased as evidenced by altered urinary trimethylamine-N-oxide and dimethylamine excretion and faecal concentrations of dimethylamine. RYGB patients’ bacteria had a greater capacity to produce tyramine from tyrosine, phenylalanine to phenylacetate and tryptophan to indole and tryptamine, compared to the microbiota from non-surgery, normal weight individuals. 3-Hydroxydicarboxylic acid metabolism and urinary excretion of primary bile acids, serum BCAAs and dimethyl sulfone were also perturbed following bariatric surgery.
Conclusion
Altered bacterial composition and metabolism contribute to metabolic observations in biofluids of patients following RYGB surgery. The impact of these changes on the functional clinical outcomes requires further investigation.
Details
- Title
- Roux-en-Y gastric bypass-induced bacterial perturbation contributes to altered host-bacterial co-metabolic phenotype
- Authors/Creators
- J.V. Li (Author/Creator) - Imperial College LondonH. Ashrafian (Author/Creator) - Imperial College LondonM. Sarafian (Author/Creator) - Imperial College LondonD. Homola (Author/Creator) - Imperial College LondonL. Rushton (Author/Creator) - Imperial College LondonG. Barker (Author/Creator) - Imperial College LondonP.M. Cabrera (Author/Creator) - Imperial College LondonM.R. Lewis (Author/Creator) - Imperial College LondonA. Darzi (Author/Creator) - Imperial College LondonE. Lin (Author/Creator) - Emory UniversityN.A. Gletsu-Miller (Author/Creator) - Indiana UniversityS.L. Atkin (Author/Creator) - Royal College of Surgeons in Ireland - BahrainT. Sathyapalan (Author/Creator) - Hull York Medical SchoolN.J. Gooderham (Author/Creator) - Imperial College LondonJ.K. Nicholson (Author/Creator) - Murdoch UniversityJ.R. Marchesi (Author/Creator) - Imperial College LondonT. Athanasiou (Author/Creator) - Imperial College LondonE. Holmes (Author/Creator) - Murdoch University
- Publication Details
- Microbiome, Vol.9(1), Art. 139
- Publisher
- BioMed Central Ltd as part of Springer Nature
- Identifiers
- 991005543820507891
- Copyright
- © 2021 The Authors.
- Murdoch Affiliation
- Centre for Computational and Systems Medicine; Health Futures Institute
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
108 File views/ downloads
57 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.120 Inflammatory Bowel Diseases & Infections
- 1.120.384 Gut Microbiota
- Web Of Science research areas
- Microbiology
- ESI research areas
- Microbiology